Muscle Weakness, Hyperactivity, and Impairment in Fear Conditioning in Tau-deficient Mice
Overview
Authors
Affiliations
Tau, one of the major neuronal microtubule-associated proteins (MAPs), is important for neuronal cell morphogenesis and axonal maintenance. Tau is also known to be a component of the paired helical filaments (PHFs) in Alzheimer's disease patients. Recently, mutations in the tau gene were found in a hereditary neurodegenerative disease called frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) which exhibits various neurological and neuropathological characteristics including PHF-like intracellular tau deposit formation. Currently, the phenotype of the disease is thought to be due to: (1) the toxicity of mutant tau molecules and and/or; (2) the loss of function of normal tau molecules in patients' brains. To test the latter hypothesis, we performed behavioral and neurological tests on tau-deficient mice. Tau-deficient mice showed muscle weakness in the wire-hanging test, hyperactivity in a novel environment, and impairment in the contextual fear conditioning. They also had a tendency to fall more easily in the rod-walking test. These phenotypes parallel some signs and symptoms of FTDP-17 patients. Our results show that the loss of tau protein may itself lead to some of the neurological characteristics observed in FTDP-17 patients.
Mitochondrial Quality Control in Alzheimer's Disease: Insights from Models.
Ganguly U, Carroll T, Nehrke K, Johnson G Antioxidants (Basel). 2024; 13(11).
PMID: 39594485 PMC: 11590956. DOI: 10.3390/antiox13111343.
Cellular and pathological functions of tau.
Bravo C, Naguib S, Gan L Nat Rev Mol Cell Biol. 2024; 25(11):845-864.
PMID: 39014245 DOI: 10.1038/s41580-024-00753-9.
Mohl G, Dixon G, Marzette E, McKetney J, Samelson A, Serras C bioRxiv. 2024; .
PMID: 38895329 PMC: 11185762. DOI: 10.1101/2024.06.04.597496.
Roth J, Rush T, Thompson S, Aldaher A, Dunn T, Mesina J Neurotherapeutics. 2024; 21(1):e00291.
PMID: 38241154 PMC: 10903085. DOI: 10.1016/j.neurot.2023.10.001.
Walker L, Attems J J Parkinsons Dis. 2023; 14(1):35-52.
PMID: 38143370 PMC: 10836576. DOI: 10.3233/JPD-230154.